Monitoring of fibrinolysis parameters during myocardial revascularization according to type of procedure

References

1 Shore-Lesserson L. Point-of-care coagulation monitoring for cardiovascular patients: past and present. J Cardiothorac Vasc Anesth 2002; 16: 99–106. 10.1053/jcan.2002.29692Search in Google Scholar

2 Koster A, Fischer T, Praus M, Haberzettl H, Kuebler WM, Hetzer R, et al. Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management Anesthesiology 2002; 97: 837–41. 10.1097/00000542-200210000-00014Search in Google Scholar

3 Kojima T, Gando S, Morimoto Y, Mashio H, Goda Y, Kawahigashi H, et al. Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery. Thromb Res 2001; 104: 301–7. 10.1016/S0049-3848(01)00379-6Search in Google Scholar

4 Despotis GJ, Avidan MS, Hogue CW Jr. Mechanisms and attenuation of hemostatic activation during extracorporeal circulation. Ann Thorac Surg 2001; 72: S1821–31. 10.1016/S0003-4975(01)03211-8Search in Google Scholar

5 Stein CM, Brown N, Vaughan DE, Lang CC, Wood AJ. Regulation of local tissue-type plasminogen activator release by endothelium-dependent and endothelium-independent agonists in human vasculature. J Am Coll Cardiol 1998; 32: 117–22. 10.1016/S0735-1097(98)00210-1Search in Google Scholar

6 Sutlić Ž, Unić D, Rudež I, Biočina B, Barić D, Kontić M. Implantation of aortic stentless bioprosthesis: case series. Croat Med J 2002; 43: 409–11. Search in Google Scholar

7 Biočina B, Sutlić Ž, Rudež I, Barić D, Unić D, Štambuk B. Multiple arterial off-pump coronary artery bypass grafting: a 5-year experience with clinical results. Heart Surg Forum 2003; 6: 132–4. Search in Google Scholar

8 McColl AJ, Keeble T, Hadjinikolaou L, Cohen A, Aitkenhead H, Glenville B, et al. Plasma antioxidants: evidence for a protective role against reactive oxygen species following cardiac surgery. Ann Clin Biochem 1998; 35: 616–23. 10.1177/000456329803500504Search in Google Scholar

9 Fears R, Esmail AF, Greenwood HC. Effect of heparin on the fibrinolytic response to plasminogen activators. Semin Thromb Hemost 1991; 17: 389–93. 10.1055/s-2007-1002641Search in Google Scholar

10 Bruce D, Spiess MD. Heparin: beyond an anticoagulant. In: Society of Cardiovascular Anesthesiologists. The relationship between coagulation, inflammation and endothelium – a pyramid towards outcome. Philadelphia: Wolters Kluwer Company, 2000:169–89. Search in Google Scholar

11 Casati V, Gerli C, Franco A, Della Valle P, Benussi S, Alfieri O, Torri G, et al. Activation of coagulation and fibrinolysis during coronary surgery: on-pump versus off-pump techniques. Anesthesiology 2001; 95: 1103–9. 10.1097/00000542-200111000-00013Search in Google Scholar

12 Hunt BJ, Parratt RN, Segal HC, Sheikh S, Kallis P, Yacoub M. Activation of coagulation and fibrinolysis during cardiothoracic operations. Ann Thorac Surg 1998; 65: 712–8. 10.1016/S0003-4975(97)01345-3Search in Google Scholar

13 Casati V, Della Valle P, Benussi S, Franco A, Gerli C, Baili P, et al. Effects of tranexamic acid on postoperative bleeding and related hematochemical variables in coronary surgery: comparison between on-pump and off-pump techniques. J Thorac Cardiovasc Surg 2004; 128: 83–91. 10.1016/j.jtcvs.2003.10.034Search in Google Scholar PubMed

14 Kongsgaard UE, Smith-Erichsen N, Geiran O, Bjornskau L. Changes in the coagulation and fibrinolytic systems during and after cardiopulmonary bypass surgery. Thorac Cardiovasc Surg 1989; 37: 158–62. 10.1055/s-2007-1020309Search in Google Scholar

15 Khuri SF, Valeri CR, Loscalzo J, Weinstein MJ, Birjiniuk V, Healey NA. Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass. Ann Thorac Surg 1995; 60: 1008–14. 10.1016/0003-4975(95)00668-BSearch in Google Scholar

16 Comunale ME, Carr JM, Moorman RM, Robertson LK. Significance of D-dimer concentrations during and after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1996; 10: 477–81. 10.1016/S1053-0770(05)80008-4Search in Google Scholar

17 Verstraete M. Clinical application of inhibitors of fibrinolysis. Drugs 1985; 29: 236–61. 10.2165/00003495-198529030-00003Search in Google Scholar

18 Rylatt DB, Blake AS, Cottis LE, Massingham DA, Fletcher WA, Masci PP, et al. An immunoassay for human D dimer using monoclonal antibodies. Thromb Res 1983; 31: 767–78. 10.1016/0049-3848(83)90108-1Search in Google Scholar

19 Elms MJ, Bunce IH, Bundesen PG, Rylatt DB, Webber AJ, Masci PP, et al. Measurement of crosslinked fibrin degradation products – an immunoassay using monoclonal antibodies. Thromb Hemost 1983; 50: 591–4. 10.1055/s-0038-1665263Search in Google Scholar

20 Whitaker AN, Elms MJ, Masci PP, Bundensen PG, Rylatt DB, Webber AJ, et al. Measurement of crosslinked fibrin derivatives in plasma: an immunoassay using monoclonal antibodies. J Clin Pathol 1984; 37: 882–7. 10.1136/jcp.37.8.882Search in Google Scholar

21 Marder VJ, Budzynski AZ, Barlow GH. Comparison of the physicochemical properties of fragment D derivatives of fibrinogen and fragment D–D of cross-linked fibrin. Biochim Biophys Acta 1976; 427: 1–14. 10.1016/0005-2795(76)90279-8Search in Google Scholar

22 Gaffney PJ, Joe F. The lysis of crosslinked human fibrin by plasmin yields initially a single molecular complex, D-dimer-E. Thromb Res 1979; 15: 673–87. 10.1016/0049-3848(79)90177-4Search in Google Scholar

23 Dempfle C-E. Use of D-dimer assays in the diagnosis of venous thrombosis. Semin Thromb Hemost 2000; 26: 631–41. 10.1055/s-2000-13221Search in Google Scholar PubMed

24 Stowe Rinder C. Platelets and their interactions. In: Society of Cardiovascular Anesthesiologists. The relationship between coagulation, inflammation and endothelium – a pyramid towards outcome. Philadelphia: Wolters Kluwer Company, 2000:107–28. Search in Google Scholar

25 Wagner C. Plasminogen activators (PA), plasminogen activator inhibitor (PAI). In: Thomas L, editor. Clinical laboratory diagnostics. Frankfurt/Main: TH-Books Verlagsgesellschaft mbH, 1998:638–40. Search in Google Scholar